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rosurvival Bcl-2–like proteins, like Bcl-w, are thought
to function on organelles such as the mitochondrion
and to be targeted to them by their hydrophobic
COOH-terminal domain. We unexpectedly found, however,
that the membrane association of Bcl-w was enhanced dur-
ing apoptosis. In healthy cells, Bcl-w was loosely attached
 
to the mitochondrial membrane, but it was converted into
an integral membrane protein by cytotoxic signals that
induce binding of BH3-only proteins, such as Bim, or by
 
the addition of BH3 peptides to lysates. As the structure of
Bcl-w has revealed that its COOH-terminal domain occupies
the hydrophobic groove where BH3 ligands bind, dis-
P
 
placement of that domain by a BH3 ligand would displace
the hydrophobic COOH-terminal residues, allowing their
insertion into the membrane. To determine whether BH3
ligation is sufﬁcient to induce the enhanced membrane
afﬁnity, or to render Bcl-w proapoptotic, we mimicked their
 
complex by tethering the Bim BH3 domain to the NH
 
2
 
terminus of Bcl-w. The chimera indeed bound avidly to
membranes, in a fashion requiring the COOH-terminal
domain, but neither promoted nor inhibited apoptosis.
These results suggest that ligation of a proapoptotic BH3-
 
only protein alters the conformation of Bcl-w, enhances
membrane association, and neutralizes its survival function.
 
Introduction
 
Apoptosis, the conserved cell suicide process by which multi-
cellular organisms remove unwanted cells, is critical for
development and tissue homeostasis, and its abnormal regu-
lation can lead to cancer, degenerative disorders, and auto-
immunity. The demise of the cell is brought about when the
cysteine proteases, called caspases, cleave vital cellular substrates.
All caspases are synthesized in a latent form and activated to
mediate cell death. In response to most developmentally
programmed cytotoxic cues or stress stimuli, caspase activation
is governed by opposing members of the Bcl-2 protein family
(Cory and Adams, 2002). As well as members that promote
cell survival, such as Bcl-2, Bcl-x
 
L
 
, and Bcl-w, the family
includes two groups of proapoptotic proteins: those like Bax
and Bak that share three of the four Bcl-2 homology (BH)
domains, and the structurally diverse BH3-only proteins
(e.g., Bim, Bid, and Bad), which have in common with Bcl-2
only the small BH3 protein interaction domain. The BH3-
only proteins are key initiators of the cell death process, but
precisely how their association with prosurvival relatives pro-
motes apoptosis remains unclear (Huang and Strasser, 2000;
Cory and Adams, 2002). One consequence, dependent on
Bax or Bak, is the release of cytochrome 
 
c
 
 from mitochondria,
which serves as a cofactor for activation of caspase-9 by
Apaf-1, thereby unleashing a proteolytic cascade. The Bcl-2
family may, however, also regulate other initiator caspases
(Cory and Adams, 2002; Marsden et al., 2002).
Most Bcl-2 family members either normally reside on
organelles or congregate there during apoptosis. Many possess
a COOH-terminal hydrophobic domain thought to target
them to the outer mitochondrial membrane and/or the nuclear
envelope/ER. Bcl-2, for example, resides predominantly on
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the cytoplasmic face of the ER, with smaller amounts on the
outer membrane of mitochondria and the nuclear envelope
(Monaghan et al., 1992; Krajewski et al., 1993; Lithgow et
al., 1994), whereas Bcl-x
 
L
 
 is more prominent on the mito-
chondrial membrane (Gonzalez-Garcia et al., 1994; Conus
et al., 2000; Kaufmann et al., 2003). Notably, Bax, which is
essential for many forms of cell death, is normally cytosolic
but undergoes a conformational change during apoptosis
and translocates to the outer mitochondrial membrane (Hsu
et al., 1997; Wolter et al., 1997; Hsu and Youle, 1998). The
translocation and activation of Bax probably involves dis-
placement of its COOH-terminal domain from a groove on
its surface (Suzuki et al., 2000) and appears to be critical to
its function (Wolter et al., 1997; Nechushtan et al., 1999).
It may, for example, allow Bax to oligomerize in the mem-
brane and form pores (Cory and Adams, 2002; Kuwana et
al., 2002).
As prosurvival Bcl-2 proteins probably require correct
subcellular localization for their biological activity (Cory and
Adams, 2002), we have explored how the membrane associ-
ation of Bcl-w, a close structural and functional homologue
of Bcl-2 and Bcl-x
 
L
 
, is related to its prosurvival function. In
contrast to Bcl-2, which has been reported to be an integral
membrane protein (see Discussion), we unexpectedly found
that Bcl-w was only loosely associated with the membranes
in healthy cells, but that engagement of a BH3-only protein
markedly strengthened that association. A plausible explana-
tion is provided by the recently determined 3D structure
of Bcl-w (Denisov et al., 2003; Hinds et al., 2003): the
Bcl-w COOH-terminal hydrophobic residues fold across
the groove to which BH3 ligands bind (see Discussion).
Hence, engagement of a BH3 ligand by the prosurvival pro-
tein must displace the hydrophobic tail, presumably then al-
lowing it to interact tightly with membranes, as proposed to
occur with Bax (Suzuki et al., 2000). To clarify how BH3
engagement is related to Bcl-w function, we have also engi-
neered chimeric proteins that have a BH3 domain tethered
to the NH
 
2
 
 terminus of Bcl-w, mimicking the ligand-bound
state. Their behavior has allowed us to assess whether the
binding of a BH3 domain is sufficient to promote mem-
brane integration and to determine how BH3 engagement
regulates the function of Bcl-w.
 
Results
 
Damage signals enhance the membrane association 
of Bcl-w
 
Confocal microscopy of HeLa cells has indicated that Bcl-w
is located on the mitochondria (O’Reilly et al., 2001),
and we have confirmed that observation with both HeLa
cells and FDC-P1 myeloid cells (unpublished data). In
view of its clear mitochondrial localization in microscopic
studies (see next section in Results), we were surprised to
find that Bcl-w did not behave like an organelle-associated
protein on sub-cellular fractionation. Irrespective of the
method used, only an insignificant amount of Bcl-w was
recovered from membrane fractions. For example, none
was detectable in purified mitochondria (Fig. 1 A). More-
over, Bcl-w behaved entirely as a cytosolic protein on sub-
cellular fractionation of healthy FDC-P1 or HeLa cells
lysed in low digitonin buffer (Fig. 1 B, 0 h; Fig. 1, C and
D, control), as did the endogenous protein in several other
cell types, NIH3T3, Jurkat, and T cells (unpublished
data). We also fractionated lysates made without deter-
gents, either by Dounce homogenization, needle (26
gauge) lysis, freeze/thawing, or nitrogen cavitation. In ev-
ery case, rather than appearing in the pellet fraction, where
proteins of the mitochondrial membrane (voltage-depen-
dent anion channel [VDAC]/Porin) and intermembrane
space (cytochrome 
 
c
 
) were found, Bcl-w fractionated with
soluble proteins such as Bax (Fig. 1 A; unpublished data).
In contrast, Bcl-2, which is reported to be an integral
membrane protein (Chen-Levy et al., 1989; Janiak et al.,
1994), was found exclusively in the pellet fraction (Fig. 1
D, control). Thus, in healthy cells, Bcl-w appears to be
only weakly bound to membranes.
We next examined whether stress signals affected the asso-
ciation of Bcl-w with membranes. Indeed, after FDC-P1
cells expressing FLAG–Bcl-w were treated with diverse cyto-
toxic stimuli, including 
 
 
 
 irradiation (Fig. 1 B), growth fac-
tor withdrawal, or cytotoxic drugs (unpublished data), sub-
cellular fractionation revealed a significant proportion of the
protein in the membrane (pellet) fraction. This occurred be-
fore any release of cytochrome 
 
c
 
 was discernible (Fig. 1 B).
Endogenous Bcl-w of FDC-P1 (Fig. 1 C) or of HeLa cells
(Fig. 1 D) also underwent the transition when they were ex-
posed to diverse cytotoxic stimuli. The pellet-bound Bcl-w
was not released by alkali treatment (Fig. 1 C) and, hence, is
probably integrated into the membrane. Interestingly, al-
most all the endogenous protein had shifted into the pellet
fraction (Fig. 1, C and D), whereas only a portion of the
overexpressed protein had done so (Fig. 1 B), suggesting that
the binding capacity of membranes for Bcl-w is finite.
Although caspases have been reported to target some
prosurvival Bcl-2–like proteins (Cheng et al., 1997), apop-
tosis did not alter the size of Bcl-w. Nevertheless, we tested
whether caspase activation somehow induced its higher af-
finity for membranes by treating the cells with the broad-
spectrum caspase inhibitor zVAD.fmk at a concentration
that delayed cell death. Bcl-w was still recruited into the
membrane fraction in response to death signals (Fig. 1 B).
Hence, the increased affinity of Bcl-w for membranes
probably reflects a step before caspase activation.
We next analyzed the protein complexes that Bcl-w might
form by gel filtration chromatography. When lysates were
prepared from healthy cells in the absence of any detergent
(Fig. 1 E) or the presence of 1% digitonin (Fig. 1 F),
FLAG–Bcl-w eluted primarily as a soluble monomer consis-
tent with its predicted size of 22 kD. However, damage sig-
nals, such as 
 
 
 
 irradiation, induced the formation of larger
Bcl-w–containing complexes (Fig. 1 F). Their size inside
cells may be even larger, because detergent was required to
solubilize the complexes away from the membrane (pellet)
fraction.
 
Damage signals do not alter the localization of Bcl-w
 
To resolve the apparent discrepancy between the predomi-
nance of Bcl-w in the soluble fraction after subcellular frac-T
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tionation (Fig. 1) and its clear mitochondrial localization in
confocal microscopic studies, we reevaluated its localization
by immunogold EM. In accord with confocal studies, a well-
characterized rat monoclonal antibody raised against Bcl-w
(13F9) (O’Reilly et al., 2001) revealed most (66%) of the
FLAG–Bcl-w molecules around the mitochondria of both
FDC-P1 (Fig. 2 A) and NIH3T3 (Fig. 2 B) cells, and an
anti-FLAG monoclonal antibody gave an equivalent staining
pattern (unpublished data). Little FLAG–Bcl-w was found
on the nuclear and ER membranes, whereas FLAG–Bcl-2
was prevalent on those membranes (Lithgow et al., 1994)
(Fig. 2 D). As expected, the anti–Bcl-w 13F9 antibody re-
vealed far fewer endogenous Bcl-w molecules in parental
FDC-P1, NIH3T3, or HeLa cells (Fig. 2 C; unpublished
data), but examination of a number of fields confirmed that
the endogenous protein was mainly mitochondrial in all
three lines.
Our combined results suggest that Bcl-w in healthy cells is
loosely associated with mitochondria and readily dislodged
after cell lysis (Fig. 1), in contrast to the tightly associated
Bcl-2, all of which appeared as expected in the membrane
(pellet) fraction (Fig. 1 D; unpublished data).
The mitochondrial localization of Bcl-w was not changed
by death signals. EM revealed a similar proportion of Bcl-w
 
on the mitochondria of FDC-P1 cells after irradiation (Fig.
2 E) or after deprivation of growth factor (Fig. 2 F). More of
the Bcl-w molecules did appear to be clustered after the cy-
totoxic signals, consistent with the gel filtration experiments
(Fig. 1 F). However, the biological significance of Bcl-w oli-
gomers will require more investigation.
 
BH3 ligands cause tight membrane association of Bcl-w
 
Apoptosis seems to be initiated when BH3-only proteins,
unleashed by damage signals, bind to prosurvival relatives
(Huang and Strasser, 2000; Cory and Adams, 2002). As the
enhanced membrane association of Bcl-w appeared to in-
volve a step before caspase activation, we hypothesized that
it was triggered by engagement of Bcl-w by a BH3-only pro-
tein such as Bim. When FLAG–Bcl-w was immunoprecipi-
tated from lysates of FD/FLAG–Bcl-w cells that had been
exposed to a damaging agent, the complex included both the
major endogenous Bim isoforms (Bim
 
L
 
 and Bim
 
EL
 
), but nei-
ther was detectable in parallel immunoprecipitates from un-
treated cells (Fig. 3 A), confirming that apoptosis induces
their association.
As the tighter membrane association of Bcl-w correlated
with the recruitment of Bim to Bcl-w, we wished to test
whether the Bim BH3 domain could induce the transition
Figure 1. Apoptotic signals trigger membrane 
integration of Bcl-w and its oligomerization. 
(A) FLAG–Bcl-w is absent from the mitochondria 
after subcellular fractionation. FLAG-Bcl-w–
expressing FDC-P1 cells were separated into 
heavy membrane, cytosolic (C), and mitochon-
drial (mit) fractions. Equal cell numbers of the 
total cell lysate (Lys), homogenate (H), or the 
fractions were resolved by SDS-PAGE. (B) Tighter 
association of FLAG–Bcl-w with membranes after 
  irradiation (10 Gy). Healthy or irradiated FD/
FLAG–Bcl-w cells were fractionated into the 
soluble (s) and pellet (p) fractions using lysis buffer 
containing 0.025% digitonin. (C) Endogenous 
Bcl-w is soluble in healthy FDC-P1 cells but 
damage signals induce membrane association 
resistant to alkali treatment. Lysates prepared 
from healthy cells (control) or cells exposed to 
100 nM staurosporine (STS) or   irradiation 
(10 Gy) or deprived of IL-3 were fractionated into 
the soluble (s, top) or pellet (p, bottom) fractions. 
(D) Damage signals trigger membrane association 
of endogenous Bcl-w in HeLa cells. Soluble (s) 
and pellet (p) fractions of healthy HeLa cells 
(control) or 24 h after treatment with 50 Jm
 2 UV 
irradiation (UV), 1.0  g/ml etoposide (VP16), or 
10 nM staurosporine (STS). (E and F) Bcl-w is a 
soluble monomeric protein in healthy cells, but 
damage signals cause its oligomerization. Lysates 
from FD/FLAG–Bcl-w cells were fractionated by 
gel filtration chromatography after lysis without 
detergent (E) or with 1% digitonin (F). Equivalent 
portions of the indicated fractions were loaded. 
By comparison with the elution of standard size 
markers as indicated, FLAG–Bcl-w appears to be 
a soluble, monomeric protein in healthy cells
(E and top panel of F) but forms larger complexes 
after damage signals (10 Gy   irradiation; F, bot-
tom). The blots were probed for FLAG–Bcl-w with 
the anti–FLAG 9H1 or for the indicated proteins.T
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in lysates from healthy cells. To validate the use of BH3
peptides, we first measured the affinity for Bcl-w of a
Bim
 
L
 
 polypeptide, or a BH3 peptide from it, using an opti-
cal biosensor (Fig. 3, B and C). Purified recombinant Bim
 
L
 
lacking its COOH-terminal hydrophobic 27 amino acids
(Bim
 
L
 
 
 
C27) binds purified Bcl-w with high (nM) affinity
(Fig. 3 B; Hinds et al., 2003). Notably, a 26-mer peptide
spanning the BH3 domain of Bim (denoted 
 
wt
 
BH3) bound
Bcl-w as avidly as Bim
 
L
 
 
 
C27, and it competed effectively
for the binding of Bim
 
L
 
 
 
C27 (Fig. 3, B and C). Conse-
quently, we focused on this peptide and two derivatives that
have reduced affinity for Bcl-w, due to replacement of one
or more of the four hydrophobic BH3 residues that mediate
interaction with the hydrophobic groove of the prosurvival
proteins (Fig. 4 A) (Sattler et al., 1997; Petros et al., 2000;
Hinds et al., 2003). Replacement of the invariant BH3
leucine (L94 of the mouse Bim
 
L
 
) with alanine (
 
L94A
 
BH3)
reduced the binding over 50-fold, whereas a glutamate
replacement of all four key residues (
 
4E
 
BH3) abolished bind-
ing altogether (Fig. 3 B).
To test whether the BH3 peptides enhanced membrane as-
sociation of Bcl-w, lysates prepared from healthy cells were in-
cubated with 
 
wt
 
BH3, the weakly binding 
 
L94A
 
BH3, or the non-
binding 
 
4E
 
BH3. Subcellular fractionation showed that the
wild-type peptide caused both overexpressed FLAG–Bcl-w
and the endogenous protein to shift into the pellet fraction,
whereas the 
 
L94A
 
BH3 mutant peptide did so less efficiently and
 
4E
 
BH3 not discernibly (Fig. 3, D and E). Endogenous Bcl-w in
lysates of HeLa cells was affected similarly (unpublished data).
Importantly, alkali treatment did not release the mem-
brane-bound Bcl-w isolated from dying cells (Fig. 1 C) or
that tightly associated due to addition of a BH3 peptide to
lysates (Fig. 3 E). This result suggests that BH3 engagement
converts Bcl-w into an integral membrane protein (Janiak et
al., 1994), presumably by inducing a conformational change
in Bcl-w that allows integration.
Figure 2. Bcl-w is predominantly a mito-
chondrial protein in healthy and dying cells. 
(A and B) Overexpressed FLAG–Bcl-w in 
FDC-P1 (A;  52K) or NIH3T3 (B,  37K) 
cells is mainly mitochondrial. Representative 
immunogold electron microscopic images 
of cells stained with the anti–Bcl-w 13F9 
antibody were detected with 18-nm gold–
conjugated goat anti–rat antibody. (C) Scanty 
staining for endogenous Bcl-w around the 
mitochondria in parental FDC-P1 cells. 
The four insets show Bcl-w staining around 
mitochondria ( 27.5K). (D) Bcl-2 is present 
on the nuclear/ER membranes as well as the 
outer mitochondrial membranes of FDC-P1 
cells. Overexpressed Bcl-2 detected with 
the mouse monoclonal anti–Bcl-2-100 anti-
body and revealed using 20-nm gold–con-
jugated goat anti–mouse antibody. (E and F) 
Bcl-w remains closely associated with the 
mitochondria after damage signals. Staining 
of FD/FLAG–Bcl-w cells 24 h after (E) 10 Gy 
  irradiation or (F) IL-3 deprivation ( 37K). 
Arrowhead, ER; arrow, mitochondria; 
arrow with ball on end, nuclear membrane. 
N, nucleus.T
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Fusing a BH3 domain to Bcl-w abrogates binding 
of BH3-only proteins
 
We wished to determine whether the engagement of a BH3
domain by Bcl-w is sufficient in itself to cause tight mem-
brane association, and also to assess how the biological activ-
ity of Bcl-w is affected (see next section in Results). We
therefore sought to mimic a BH3-ligated conformer of Bcl-w
by fusing the 26-mer BH3 region of Bim
 
L
 
 to its NH
 
2
 
 termi-
nus via a 30-residue flexible linker (Gly
 
4
 
Ser
 
1
 
)
 
6
 
 (Bird et al.,
1988), generating 
 
wt
 
BH3/Bcl-w (Fig. 4 A). Control Bcl-w
constructs had mutant forms of the BH3 with reduced bind-
ing affinity fused to Bcl-w (Table I).
In the chimeras, the 
 
wt
 
BH3, but not the 
 
4E
 
BH3, peptide
would be expected to occupy the binding groove of Bcl-w and
displace its COOH-terminal residues (Fig. 4, C and D, left).
To determine whether the binding groove of the chimeras re-
mained accessible, we tested their ability to bind to Bim
 
EL
 
 or
Bmf, another BH3-only protein (Puthalakath et al., 2001), in
coimmunoprecipitation assays (the Bim
 
EL
 
 isoform was used
rather than Bim
 
L
 
, because Bim
 
EL
 
 was more readily resolved by
size from Bcl-w). As expected, the 
 
4E
 
BH3/Bcl-w chimera still
bound Bim
 
EL
 
 and Bmf (Fig. 4 D; unpublished data), showing
that its groove remained free, whereas the 
 
wt
 
BH3/Bcl-w chi-
mera did not (Fig. 4 C), presumably because its groove was al-
ready occupied by the tethered BH3.
 
BH3 binding to Bcl-w triggers membrane association 
and neutralizes prosurvival activity
 
As the fusion constructs behaved as expected, to allow tests of
their function, we stably expressed them in FDC-P1 cells and
derived at least three independent clones of each construct ex-
pressing comparable levels of the chimeras (Fig. 5 A). First, we
confirmed that the tethered BH3 domain did not affect the
predominant mitochondrial localization of Bcl-w (Fig. 5, B
and C). Next, we examined the membrane binding properties
of the chimeras (Fig. 5 D and Table I). The 
 
wt
 
BH3/Bcl-w
construct was predicted to bind membranes more tightly, be-
cause its COOH terminus should be displaced, mimicking
the conformation of wild-type Bcl-w with a BH3 protein
bound. Indeed, fractionation of healthy cells revealed that a
substantial proportion of the 
 
wt
 
BH3/Bcl-w appeared in the
pellet fraction, as observed with Bcl-w only after cell death in-
duction (Fig. 1). In contrast, the 
 
4E
 
BH3/Bcl-w chimera, as ex-
pected, appeared almost entirely in the soluble fraction, like
wild-type Bcl-w (Fig. 5 D). Significantly, the translocation of
 
wt
 
BH3/Bcl-w requires its COOH-terminal domain, because
the chimera with that domain excised no longer firmly at-
tached to the membranes (Fig. 5 E). Hence, it is the displaced
“tail” that mediates tight membrane binding.
Finally, we tested whether the conformational change me-
diated by the bound BH3 domain induces a latent killing
Figure 3. BH3 peptides induce tight 
membrane association of Bcl-w. 
(A) Damage signal (10 Gy   irradiation) 
to FD/FLAG–Bcl-w cells provokes BimEL 
and BimL isoforms to associate with 
FLAG–Bcl-w. (B) Wild-type BimL protein 
and its BH3 peptide bind tightly to Bcl-w. 
The affinities of recombinant BimL C27 
or 26-mer Bim BH3 peptides to recombi-
nant Bcl-w  C10 determined in optical 
biosensor. (C) Bim BH3 peptide (
wtBH3) 
binds Bcl-w as well as BimL  C27. 
The ability of free BimL C27 or 
wtBH3 
peptide to compete with immobilized 
BimL C27 for Bcl-w binding was assessed 
in biosensor experiments. (D) Addition 
of wild-type, but not mutant, BH3 pep-
tide induces tight membrane association 
of FLAG–Bcl-w. Lysates of healthy cells 
were incubated with increasing amounts 
(0–100  g/ml) of 
wtBH3 (top) or 
L94ABH3 
(bottom) peptides before fractionation. 
The blots were probed with rat anti–FLAG 
9H1 to detect FLAG–Bcl-w. (E) Bim BH3 peptide induces tighter association of endogenous Bcl-w from FDC-P1 cells. Lysates of healthy cells 
were incubated with increasing amounts of BH3 peptides and fractionated. In D and E, the blots were probed for endogenous Bcl-w. (F) BH3 
peptide induces membrane integration of endogenous Bcl-w. Lysates prepared from healthy FDC-P1 cells and incubated with 
wtBH3 peptide 
were fractionated without or with alkali treatment.
 
Table I. 
 
Properties of BH3/Bcl-w fusions
Construct BH3 binding Membrane attachment Mitochondrial localization Inhibition of apoptosis
 
Wild-type Bcl-w
 
     
 
Yes
 
   
 
wt
 
BH3/Bcl-w
 
    
 
Yes
 
 
 
4E
 
BH3/Bcl-w
 
     
 
Yes
 
   
 
4A
 
BH3/Bcl-w
 
  
 
ND
 
 
 
Chimeras having the BH3 peptide from Bim fused to Bcl-w were compared with wild-type Bcl-w.T
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activity in Bcl-w. That conformer might, for example, upon
integration into the membrane, disturb its integrity, as
translocated Bax is thought to do (see Discussion). 
 
wt
 
BH3/
Bcl-w did not, however, affect the viability of untreated
FDC-P1 cells, and when they were subjected to cytotoxic
stress, it did affect the loss of mitochondrial transmembrane
potential (
 
  
 
m
 
), which sometimes precedes irreversible
commitment to apoptosis (Castedo et al., 1996). In con-
trast, 
 
4E
 
BH3/Bcl-w inhibited the loss of 
 
  
 
m
 
 as effectively
as wild-type Bcl-w (Fig. 6 A).
Importantly, the 
 
4E
 
BH3/Bcl-w chimera promoted survival
as effectively as wild-type Bcl-w (Fig. 6 and Table I), show-
ing that the addition of an NH2-terminal peptide does not
in itself impair the biological activity of Bcl-w. Moreover, a
chimera in which the four critical BH3 hydrophobic resi-
dues were replaced with alanines rather than glutamates
(
4ABH3/Bcl-w) was partially active (Table I); as would be ex-
pected, because this BH3 peptide should present a weakly
hydrophobic face for interaction with Bcl-w. In striking
contrast, the 
wtBH3/Bcl-w chimera neither conveyed any
protection from death stimuli nor sensitized the cells to
them. Thus, this chimera, which mimics a BH3-bound Bcl-w,
was functionally inert, neither inhibiting nor promoting cell
death (Fig. 6 and Table I).
Discussion
The association of the related prosurvival proteins Bcl-2,
Bcl-xL, and Bcl-w to intracellular membranes is likely to
be closely coupled to their activity. Because all three pos-
sess similar hydrophobic COOH-terminal hydrophobic do-
mains, it was widely assumed that all would be integral
membrane proteins distributed similarly between the cyto-
plasmic faces of the nuclear/ER and outer mitochondrial
membranes. Notable differences have, however, appeared.
The majority of the Bcl-2 molecules reside on the nuclear/
ER membrane, with a smaller portion on that of mitochon-
dria, whereas Bcl-xL is more prominent on the latter (Gonza-
lez-Garcia et al., 1994; Conus et al., 2000; Kaufmann et al.,
2003), where we also find most of the Bcl-w in healthy cells
(Fig. 2). The precise mechanism by which the Bcl-2–related
proteins are targeted to these membranes remains unknown
(Wattenberg and Lithgow, 2001; Borgese et al., 2003).
Bcl-2 can be readily isolated from membrane fractions
(Hsu et al., 1997; Hausmann et al., 2000) and seems to be
an integral membrane protein (Chen-Levy et al., 1989; Ja-
niak et al., 1994). Although one study suggests that Bcl-xL
may be an integral membrane protein (Kaufmann et al.,
2003), a substantial portion of the protein is readily dis-
placed from membranes and thus cannot be integrated
(Hsu et al., 1997; Hausmann et al., 2000; Nijhawan et al.,
2003). We found that Bcl-w binds very weakly to mem-
branes in healthy cells but that its affinity is dramatically
enhanced in dying cells, where it appears to become an in-
tegral membrane protein (Fig. 1). Rather than a late event
requiring caspase activation, this transition seems to be
mediated by the binding of a BH3-only protein, such as
Bim, and is thus associated with the initiation of cell death
(Huang and Strasser, 2000). Engagement of the BH3 do-
main alone must suffice, because addition of a Bim BH3
Figure 4. Fusion of Bim BH3 to Bcl-w 
blocks engagement of BH3-only proteins. 
(A) Representation of the constructs fusing 
Bim BH3 to the NH2 terminus of Bcl-w. 
The shaded box below represents the 
core BH3 domain, and asterisks mark 
the hydrophobic BH3 residues critical 
for Bcl-w binding and altered to alanine 
(A) or glutamate (E) in the mutant pep-
tides. (B) Bcl-w interacts avidly with 
Bim. 
35S metabolically labeled lysates 
prepared from 293T cells overexpressing 
FLAG–Bcl-w and EE BimEL were immuno-
precipitated with the anti–FLAG M2 
( F), anti-EE ( E), or anti-HA ( H) anti-
bodies, and the immunoprecipitations 
were size fractionated on SDS-PAGE 
gels. (C) Fusion of wild-type Bim BH3 
peptide to Bcl-w blocks its binding to 
Bim. 
wtBH3 (filled triangle), linked to 
Bcl-w via a flexible linker (in gray), is 
likely to bind onto the groove of Bcl-w, 
thereby displacing the COOH terminus 
(left). As expected, FLAG–
wtBH3/Bcl-w 
could not be coimmunoprecipitated 
with BimEL. (D) Fusing a BH3 with the 
key BH3 hydrophobic residues mutated 
(filled circle) did not affect binding to 
BH3-only proteins. In the 
4EBH3/Bcl-w 
fusion, the groove should be unoccupied 
(left), and that chimera readily associated 
with BimEL.T
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peptide to lysates induced a change in the membrane asso-
ciation of Bcl-w indistinguishable from that observed in
cells induced to die (compare Figs. 1 and 3). Similar con-
clusions have been reached regarding Bcl-xL (Youle, R.,
personal communication).
As the BH3-only proteins bind the prosurvival proteins
with high specificity and affinity, we propose that their liga-
tion promotes membrane integration by altering the confor-
mation of the prosurvival protein. Although the Bcl-xL struc-
ture does not exhibit a large conformational change when a
BH3 peptide is bound (Sattler et al., 1997; Petros et al.,
Figure 5. Bim BH3 fusion drives Bcl-w into the membrane fraction. 
(A) Expression of FLAG-tagged Bcl-w, 
wtBH3/Bcl-w, or 
4EBH3/Bcl-w 
fusion proteins in FDC-P1 cells. Representative clones (unfilled 
histograms) were stained with the anti–FLAG M2 followed by FITC-
conjugated goat anti–mouse antibody and analyzed by flow cytometry. 
Filled histograms indicate control staining of the parental FDC-P1 
cells. (B and C) BH3/Bcl-w fusions are localized at the mitochondria. 
Immunogold EM revealing 
wtBH3/Bcl-w (B) or 
4EBH3/Bcl-w (C) in 
FDC-P1 cells ( 37K). Arrows indicate some gold particles located 
on mitochondria. (D) 
wtBH3/Bcl-w, but not 
4EBH3/Bcl-w, associates 
with the membrane fraction of healthy cells. The cells were lysed 
in buffer containing 0.025% digitonin before fractionation. (E) The 
COOH-terminal domain of Bcl-w is essential for targeting Bcl-w 
into the membrane fraction. Fractionation of cells transiently 
expressing 
wtBH3/Bcl-w (left) or 
wtBH3/Bcl-w  C29 (right). Equivalent 
fractions were resolved by SDS-PAGE and then blotted.
Figure 6. Fusing wild-type BH3 to Bcl-w does not perturb 
mitochondrial transmembrane potential (  m) but inactivates 
its prosurvival activity. (A) Flow cytometric analysis of untreated 
(left), IL-3–deprived (middle), or  -irradiated (right) parental FDC-P1 
cells or representative clones stably expressing Bcl-w, 
wtBH3/Bcl-w, 
or 
4EBH3/Bcl-w stained with the fluorochrome DiOC6(3) and PI. 
DiOC6(3) staining is shown after appropriate compensation for PI to 
exclude dead cells. (B) Parental FDC-P1 cells or representative clones 
of cell lines stably expressing Bcl-w, 
wtBH3/Bcl-w, or 
4EBH3/Bcl-w 
fusion proteins were deprived of their growth factor IL-3 or  -irradiated 
(10 Gy). Cell viability was quantified daily by PI staining revealed 
by flow cytometric analyses. The data are means   1 SD of three 
or more experiments.T
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2000; Liu et al., 2003), a caveat is that those structures were
derived from a Bcl-xL protein lacking the hydrophobic
COOH-terminal domain. Interestingly the structure of full-
length proapoptotic Bax, a cytosolic protein, revealed that its
hydrophobic COOH-terminal residues forms an   helix that
nestles into a hydrophobic groove that is very similar to that
used by prosurvival relatives to bind BH3 peptides (Suzuki et
al., 2000). It has been proposed that the orientation of the
COOH-terminal hydrophobic residues alters Bax localiza-
tion, because damage signals induce Bax to translocate from
the cytosol to mitochondrial membranes, where it forms oli-
gomers (Nechushtan et al., 1999; Antonsson et al., 2001;
Mikhailov et al., 2001; Nechushtan et al., 2001). As Bax, or
its close relative Bak, is essential to signal many forms of cell
death (Lindsten et al., 2000), the conformational alteration
in Bax and Bak may represent a critical step in apoptosis.
Bcl-w may also undergo a conformational switch of the
COOH terminus, like that proposed for Bax. Our recent so-
lution structure of Bcl-w lacking only the last 10 residues
(Hinds et al., 2003) unexpectedly revealed that its COOH-
terminal hydrophobic residues, like that of Bax, are tucked
into the hydrophobic groove, occupying the site where a
BH3 domain binds in Bcl-xL (Sattler et al., 1997; Petros et
al., 2000; Liu et al., 2003). Therefore, a BH3 ligand must
displace the sticky hydrophobic residues and thus make it
available to insert into a lipid environment. The membrane
integration of Bcl-w after a death signal (Fig. 1) probably re-
flects insertion of the COOH-terminal domain into the
membrane after its displacement from the groove by the en-
gagement of a BH3-only protein. It is unlikely that mem-
brane integration requires an independent signal, or is an in-
direct consequence of apoptosis, because the transition
could be triggered simply by BH3 peptides added to lysates
of healthy cells (Fig. 3), and a Bcl-w chimera having a teth-
ered wild-type BH3 domain was integrated even in healthy
cells (Fig. 5).
Previous analysis of the binding of BH3-only proteins to
prosurvival relatives has not clearly established whether their
association simply neutralizes the function of the latter or in-
stead converts the Bcl-2–like protein into a Bax-like “killer.”
The similarity of the structure of Bcl-xL to the pore-forming
domain of bacterial toxins (Muchmore et al., 1996) has stim-
ulated interest in the hypothesis that Bcl-2–like proteins form
pores in the mitochondrial membranes (Vander Heiden and
Thompson, 1999; Tsujimoto and Shimizu, 2000; Zamzami
and Kroemer, 2001) and thereby control the release of proap-
optogenic factors such as cytochrome c (Green and Reed,
1998; Gross et al., 1999; Martinou and Green, 2001). In
such a model, binding of a BH3-only protein to a Bcl-2–like
protein might well initiate pore formation, leading to cell
death. Our studies, however, indicate that this is unlikely, be-
cause a chimera that mimics a BH3-bound conformer of Bcl-w
had no deleterious effects on the cell (Fig. 6). Genetic studies
also argue against the idea that the mammalian prosurvival
proteins harbor a latent killing activity because their deletion
in the mouse leads to tissue degeneration and loss of cell via-
bility, rather than the hyperplasia that would be predicted if
these proteins mediate killing (Cory and Adams, 2002).
The finding that the 
wtBH3/Bcl-w chimera is inert rather
than proapoptotic is compatible with other mechanisms for
the function of Bcl-2–like proteins. For example, if Bcl-2–
like proteins simply sequester BH3-only proteins until their
capacity is exceeded, as has been proposed (Lindsten et al.,
2000; Cheng et al., 2001; Zong et al., 2001), this chimera
would be inert because it can no longer bind BH3-only pro-
teins. A second, more radical, hypothesis would be that in-
sertion into the membrane actually inactivates the prosur-
vival function of Bcl-w, and hence the weakly membrane
attached form of Bcl-w might be the active form.
We favor a model in which Bcl-2–like proteins normally
sequester a postulated downstream effector, needed for acti-
vation of Bax/Bak and/or caspases (Fig. 7) (Cory and Ad-
ams, 2002). In this model, the chimera might be inactive be-
cause it can no longer bind the effector. If so, such an
effector (X) might be bound only by the conformer of Bcl-w
with the COOH-terminal residues in the groove but dis-
placed upon BH3 binding of Bcl-w. Interestingly, although
the COOH-terminal residues of Bcl-w are dispensable for
binding to BH3-only proteins, they are essential for the bio-
logical activity of Bcl-w (Hinds et al., 2003). That observa-
tion, together with the data presented here, prompts us to
predict that the COOH-terminal residues of prosurvival
family members are required for binding to a membrane-
bound effector protein akin to that proposed in Fig. 7.
Materials and methods
Expression constructs
Expression vectors for Bcl-w, BimEL, or Bmf have been previously de-
scribed (O’Connor et al., 1998; Moriishi et al., 1999; Puthalakath et al.,
2001). These are based on the pEF PGKpuro or pEF PGKhygro vectors in-
corporating NH2-terminal FLAG and Glu-Glu (EE) epitopes, respectively
(Huang et al., 1997a,b, 1998). To make the BH3/Bcl-w fusions, oligonu-
cleotides corresponding to the 26 residues spanning wild-type or mutant
BH3 of Bim were joined to wild-type Bcl-w by a flexible (Gly4Ser1)6 linker.
Bacterial expression vectors to make recombinant Bcl-w or BimL proteins
are described elsewhere (Hinds et al., 2003). Proofreading Pfu polymerase
(Stratagene) was used for PCR, and the constructs were verified by auto-
mated sequencing. Details of the oligonucleotides and the constructs are
available from the authors.
Figure 7. Model for the inactivation of prosurvival Bcl-2–like 
proteins by the BH3-only proteins. It is proposed that prosurvival 
family members, like Bcl-w, normally bind and sequester a 
membrane-bound effector protein (X) required for Bax/Bak activation. 
The engagement of a BH3-only protein (Bim here) frees X and 
allows it, directly or indirectly, to activate Bax and Bak, thereby 
initiating apoptosis.T
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Tissue culture, transfection, and cell survival assays
The culture conditions of the cell lines used and the transfection conditions
have been previously described (Strasser et al., 1995; O’Reilly et al., 1996;
Huang et al., 1997a,b, 1998; O’Connor et al., 1998; Puthalakath et al.,
1999; Hausmann et al., 2000; Puthalakath et al., 2001). Cell death was in-
duced in FDC-P1 cells by IL-3 deprivation, 10 Gy   irradiation, or 1–100
nM staurosprorine (Sigma-Aldrich); in HeLa cells with 50 Jm
 2 UV irradia-
tion, 1.0  g/ml etoposide (VP-16; Della West), or 10 nM staurosporine. Cell
viability was quantified by flow cytometric analysis of cells excluding 5  g/
ml propidium iodide (PI) (Sigma-Aldrich) using a FACScan
® (Becton Dickin-
son). Each time point was performed in triplicate on at least three indepen-
dent clones of each genotype, and the experiments were repeated at least
three times. In some experiments, the cells were cultured in the presence of
a broad-spectrum caspase inhibitor, 50  M zVAD.fmk (Bachem).
Cytofluorometric determination of mitochondrial 
transmembrane potential
To assess mitochondrial transmembrane potential (  m), healthy or dying
cells were incubated for 15 min at 37 C in buffer containing 40 nM 3,3 -
dihexyloxacarbocyanine iodide (DiOC6[3]; Molecular Probes) before add-
ing 5  g/ml of PI. The cells were kept on ice until flow cytometric analysis.
After compensation to exclude nonviable cells, fluorescence was recorded
at 525 nM (FL-1) for DiOC6(3) and 600 nM (FL-3) for PI on a FACScan
®
(Becton Dickinson).
Subcellular fractionation, gel filtration, immunoprecipitation, 
and immunoblotting
Fractionation of whole cell lysates into the soluble and pellet fractions was
previously described (Ramsby et al., 1994; Hausmann et al., 2000). In
brief, cells lysed in HMKEE buffer (20 mM Hepes, pH 7.2, 5 mM MgCl2, 10
mM KCl, 1 mM EDTA, 1 mM EGTA, and protease inhibitors) containing
250 mM sucrose and 0.025% digitonin (Calbiochem) were left on ice for
10 min, and then the organelles, cytoskeleton, and membranes were pel-
leted by centrifugation (13,000 rpm, 2 min at 4 C). The pellet was solubi-
lized in RIPA buffer (150 mM NaCl, 1% Triton X-100, 0.5% deoxycholic
acid, 0.1% SDS, 50 mM Tris-HCl, pH 8.0, and protease inhibitors). The
protease inhibitors used include Pefabloc SC, soybean trypsin inhibitor,
leupeptin, aprotinin, E64, and pepstatin (Sigma-Aldrich or Roche).
Mitochondria were isolated by swelling cells in hypotonic RSB buffer
(10 mM NaCl, 1.5 mM MgCl2, 10 mM Tris-HCl, pH 7.5) at 4 C for 5–10
min (Lithgow et al., 1994; Spector et al., 1998). The cells were lysed using
Dounce homogenization, and the osmotic balance was restored by addi-
tion of 2.5  MS buffer (525 mM mannitol, 175 mM sucrose, 12.5 mM
Tris-HCl, pH 7.5, 2.5 mM EDTA, pH 7.5). Mitochondria were then isolated
by differential centrifugation: 1,300 g for 5 min (removing nuclei and large
membrane fragments), and the supernatant was centrifuged three times at
17,000 g for 15 min to isolate mitochondria. The final mitochondrial pellet
was resuspended in 1  MS buffer. Other mitochondrial isolation proce-
dures used include those described by Antonsson et al. (2001), Hagen-
büchle and Wellauer (1992), and Wei et al., (2000). Alkali (0.1 M Na car-
bonate, pH 11.5) treatment of membrane pellets was performed as
previously described (Janiak et al., 1994).
Cells for gel filtration were swollen in HMKEE buffer and lysed by nitro-
gen cavitation. Adding sucrose to 250 mM restored the osmolarity. After
removing insoluble material by centrifugation, lysates from 5   10
7 cells
were loaded onto an analytical Superdex™ 75 column (Amersham Bio-
sciences) and run at 0.5 ml/min, and 0.2-ml fractions were collected. Al-
ternatively, lysates from a similar number of cells, lysed in HMKEE buffer
containing 250 mM sucrose and 1% digitonin, were resolved using an an-
alytical Superose™ 12 column (Amersham Biosciences) under similar con-
ditions. The columns were calibrated using standard protein markers (Am-
ersham Biosciences).
Lysates from transiently transfected and [
35S]methionine/cysteine (NEN)-
labeled cells were prepared and coimmunoprecipitation experiments were
performed as previously described (Huang et al., 1997a,b, 1998; O’Con-
nor et al., 1998; Moriishi et al., 1999; Puthalakath et al., 1999, 2001). To-
tal cell lysates, immunoprecipitates, or fractionated samples were resolved
by SDS-PAGE (Invitrogen) and electroblotted onto nitrocellulose mem-
branes (Amersham Biosciences). Immunoblotting was performed as previ-
ously described (Huang et al., 1997a,b, 1998; O’Connor et al., 1998;
Moriishi et al., 1999; Puthalakath et al., 1999, 2001; Hausmann et al.,
2000). The following antibodies were used: mouse monoclonal anti–FLAG
M2 (Sigma-Aldrich), anti–voltage-dependent anion channel (VDAC)/Porin
(Calbiochem), anti–cytochrome c (7H8.2C1; BD Biosciences), anti–Bcl-2-
100 (Pezzella et al., 1990), anti–Bax 5B7 (Sigma-Aldrich), anti-EE (Glu-
Glu) (CRP), or anti-HA.11 (CRP); rat monoclonal anti–FLAG 9H1, anti–Bcl-w
13F9, or anti–Bcl-w 16H12 (O’Reilly et al., 2001); and rabbit polyclonal
anti–caspase-9 (BD Biosciences). The rat monoclonal anti-FLAG antibody
was generated by immunizing rats with FLAG-tagged recombinant human
Apaf-1 protein (Hausmann et al., 2000) and screened using a FDC-P1 cell
line overexpressing FLAG–Bcl-2 (O’Reilly et al., 1998).
Recombinant proteins, peptides, and binding experiments
Recombinant Bcl-w and BimL proteins, expressed as GST fusion proteins in
Escherichia coli BL21(DE3), were prepared as previously described (Day et
al., 1999; Hinds et al., 1999, 2003). Bcl-w  C10, harboring the mutations
C29S and A128E, was subcloned into the vector pQE-9 (QIAGEN) to allow
NH2-terminal tagging with the His6 epitope. The mutations did not ad-
versely affect the structure of Bcl-w or its binding properties (Hinds et al.,
2003; not depicted) but prevented nonspecific dimerization and aggrega-
tion. This protein, referred to as Bcl-w  C10, was prepared by affinity puri-
fication using a nickel chelate column according to the manufacturer’s
instructions (QIAGEN) and size exclusion chromatography. Peptides corre-
sponding to the following sequences were purchased from Mimotopes:
wtBH3, DLRPEIRIAQELRRIGDEFNETYTRR; 
L94ABH3, DLRPEIRIAQEARRIG-
DEFNETYTRR; and 
4EBH3, DLRPEIREAQEERREGDEENETYTRR. The al-
tered amino acids are in bold.
Analysis of protein interactions was performed on a Biacore 2000 bio-
sensor (Biacore) as previously described (Lackmann et al., 1997; Hinds et
al., 2003). BimL C27 or BH3 peptides were immobilized to Biacore CM 5
sensor chips using N-hydroxysuccinimide coupling. The binding kinetics
were derived from the sensorgrams after subtraction of baseline responses
by “global analysis” using the BIA Evaluation software (version 3.02; Bia-
core). The ability of Bim-derived BH3-domain peptides to compete for Bim
binding in solution was examined by incubation of a constant concentra-
tion of Bcl-w (50 nM) ligand with increasing amounts of BimL C27 or BH3
peptides before analysis on a Bim-derivatized sensor chip.
To test if BH3 peptides induce tight membrane binding of Bcl-w, cell ly-
sates prepared in HMKEE buffer (with 250 mM sucrose and 0.025% digito-
nin) were incubated with 1–100  g/ml of the peptide for 30 min at room
temperature before fractionation.
Immunogold EM
Cell pellets, frozen using a Leica EM high-pressure freezer, were freeze
substituted in 0.1% uranyl acetate in acetone at  90 C for 72 h, and the
temperature was raised to  50 C at 6 C/h. The samples were infiltrated
with a graded series of Lowicryl HM20 low temperature resin (Poly-
sciences) in acetone consisting of 25% resin (8 h), 50% resin overnight,
75% resin (8 h), and 100% resin overnight. The infiltrated samples were
polymerized under UV light for 48 h at  50 C and brought to room tem-
perature at 6 C/h. The sample blocks were further hardened under UV
light for 24 h at room temperature. Embedded cell blocks were sectioned
with a diamond knife (Leica Ultracut R microtome), and 90-nm sections
were collected onto Formvar-coated 200-mesh hexagonal copper grids.
Prior to immunolabeling, sections were blocked in PBS containing 0.8%
BSA/0.01% Tween 80 for 30 min. The grids were incubated for 4 h at
room temperature on 20- l droplets containing 10  g/ml rat anti–Bcl-w
13F9, rat anti–FLAG 9H1, mouse anti–Bcl-2-100, or isotype control (BD
Biosciences) antibodies diluted with blocking agent. After three washes in
blocking agent, the grids were incubated overnight on 20- l droplets of
18-nm gold–conjugated goat anti–rat secondary antibody (1:40; Jackson
ImmunoResearch Laboratories) or 20-nm gold–conjugated anti–mouse
secondary antibody (1:40; British Biocell) at 4 C. Labeled grids were
washed three times, immersed in distilled water, and allowed to air dry.
They were then sequentially stained with saturated uranyl acetate for 15
min and triple lead stain for 10 min (Sato, 1968) and viewed on a Philips
CM120 Biotwin transmission electron microscope at 120 kV. Quantifica-
tion for mitochondrial-associated staining was performed on at least 36
negatives and scored independently.
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